Literature DB >> 5116036

Effects of methysergide on platelets incubated with reserpine.

J N Cumings, B P Hilton.   

Abstract

1. Platelets were incubated with methysergide and related compounds (2-bromo lysergic acid (BOL), ergotamine and methyl ergotamine) together with reserpine.2. Methysergide inhibited the normal aggregation response of platelets to 5-hydroxytryptamine (5HT) but did not affect the reduction in the 5HT content caused by reserpine, or the uptake of 5HT by the platelets.3. BOL, ergotamine and methyl ergotamine behaved similarly. Methysergide had greater anti5HT potency than BOL, and methyl ergotamine had greater potency than ergotamine.4. The use of platelets as a model for synaptic preparations is discussed.5. The role of 5HT receptor sites on the platelet membrane and the significance of the results for migraine patients treated with methysergide are discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5116036      PMCID: PMC1665757          DOI: 10.1111/j.1476-5381.1971.tb07145.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.

Authors:  F SICUTERI
Journal:  Triangle       Date:  1963-10

2.  METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.

Authors:  J R GRAHAM
Journal:  N Engl J Med       Date:  1964-01-09       Impact factor: 91.245

3.  5-hydroxytryptamine antagonists.

Authors:  L GYERMEK
Journal:  Pharmacol Rev       Date:  1961-09       Impact factor: 25.468

4.  Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin.

Authors:  W DOEPFNER; A CERLETTI
Journal:  Int Arch Allergy Appl Immunol       Date:  1958

Review 5.  Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.

Authors:  A Pletscher
Journal:  Br J Pharmacol Chemother       Date:  1968-01

6.  Effects of 5-hydroxytryptamine on platelet aggregation.

Authors:  H R Baumgartner; G V Born
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

7.  Comparative trial of serotonin antagonists in the management of migraine.

Authors:  J W Lance; M Anthony; B Somerville
Journal:  Br Med J       Date:  1970-05-09

8.  Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

Authors:  D A Curran; H Hinterberger; J W Lance
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

9.  Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25.

Authors:  R J Boakes; P B Bradley; I Briggs; A Dray
Journal:  Br J Pharmacol       Date:  1970-10       Impact factor: 8.739

10.  An assessment of platelet aggregation induced by 5-hydroxytryptamine.

Authors:  B P Hilton; J N Cumings
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

View more
  3 in total

1.  Effects of reserpine and chlorpromazine on 5-hydroxytryptamine uptake of platelets from migrainous and control subjects.

Authors:  B P Hilton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

2.  Effects of ergotamine and methysergide on blood platelet aggregation responses of migrainous subjects.

Authors:  B P Hilton; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-05       Impact factor: 10.154

3.  5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache.

Authors:  B P Hilton; J N Cumings
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.